P53 IHC Result as a Prognostic Tool in MDS

BACKGROUND & OBJECTIVE: Some of the patients with myelodysplastic syndrome (MDS) are categorized as good prognosis based on the Revised International Prognostic Scoring System (IPSS-R). However, these patients may have poor clinical outcomes. It seems that the current diagnostic tools and IPSS-R...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezvani, Alireza, Monabati, Ahmad, Kargar, Zahra, Safaei, Akbar, Mahmoodzadeh, Mahdi, Moosapour, Hamideh, Hosseini, Marzieh, Taheri, Abdolmajid, Kheiri, Soleiman, Taheri, Elham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Society of Pathology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628383/
https://www.ncbi.nlm.nih.gov/pubmed/37942201
http://dx.doi.org/10.30699/IJP.2023.1971023.2991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628383/
https://www.ncbi.nlm.nih.gov/pubmed/37942201
http://dx.doi.org/10.30699/IJP.2023.1971023.2991

Ejemplares similares